当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Artificial Intelligence to Improve Drug Safety and Toxicology

Lora L Cncela

The field of drug safety and toxicology is vital for ensuring the safety and effectiveness of pharmaceutical products. However, traditional approaches to drug safety assessment and toxicological studies are often resource-intensive, timeconsuming, and reliant on animal testing, presenting ethical concerns. In recent years, artificial intelligence (AI) has emerged as a promising solution to revolutionize drug safety and toxicology research. This dissertation aims to explore the applications of AI in enhancing drug safety and toxicology, examine the associated challenges and limitations, and propose potential solutions for future advancements. The study will provide an overview of AI techniques, including machine learning, deep learning, and natural language processing, and their relevance to drug safety and toxicology. It will assess the benefits and challenges of implementing AI in this field, such as improved predictive modeling of drug toxicity, computational models for pharmacokinetics and pharmacodynamics, drug repurposing, and detection of adverse drug reactions. Additionally, ethical considerations, data availability and quality, and regulatory and legal implications will be discussed. The dissertation will conclude with future perspectives, recommendations, and the potential impact of AI on drug safety and toxicology research, ultimately contributing to the advancement of this critical field.